edrophonium has been researched along with rapacuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danjoux, G; Hing, JP; Hunter, JM; Mills, KG; Pollard, BJ; Scott, JM; Wright, PM | 1 |
| Belmont, MR; Lien, CA; Savarese, JJ; Suzuki, T; Tjan, J | 1 |
2 trial(s) available for edrophonium and rapacuronium
| Article | Year |
|---|---|
Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Topics: Adolescent; Adult; Aged; Cholinesterase Inhibitors; Drug Administration Schedule; Edrophonium; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 1999 |
Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
Topics: Adolescent; Adult; Androstanols; Atracurium; Cholinesterase Inhibitors; Edrophonium; Electric Stimulation; Humans; Isoquinolines; Laryngeal Muscles; Male; Middle Aged; Mivacurium; Neuromuscular Blockade; Neuromuscular Blocking Agents; Rocuronium; Time Factors; Treatment Outcome; Vecuronium Bromide | 2003 |